FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3205422661> ?p ?o ?g. }

• W3205422661 endingPage "353" @default.
• W3205422661 startingPage "345" @default.
• W3205422661 abstract "La monitorización flash de glucosa (MFG) mejora algunas variables de control glucémico y parámetros de calidad de vida. Objetivo Evaluar la calidad de vida y el control glucémico tras el inicio de MFG en pacientes con DM1 en la práctica clínica. Estudio observacional prospectivo en pacientes con DM1 que iniciaron MFG (de junio de 2019 a abril de 2020). Se evaluaron las puntuaciones de: cuestionario de calidad de vida específico para la diabetes mellitus (EsDQOL), escala de distrés relacionado con la diabetes (EsDDS), Diabetes Treatment Satisfaction Questionnaire (EsDTSQ) y variables de control glucémico al inicio y a los 3 meses de MFG. Se seleccionó a 114 pacientes, el 56% varones, con una edad media de 37,2 años (DE 12,4) con 18,7 años (DE 11,5) de DM1. El 24,6% tenía infusión subcutánea contínua de insulina. Se observaron diferencias (basalmente vs. 3 meses) en la puntuación de EsDTSQ (22 [15,5-27] vs. 25 [22-28]; p < 0,001) y en el EsDQOL (88 [74-104] vs. 84 [70-101]; p = 0,017), pero no en la EsDDS. La HbA1c fue 7,8% (1,3) vs. 7,4% (1,1); p < 0,001), sin mejoría en otras variables de control glucémico, salvo el número medio de eventos de hipoglucemia/14 días: 14 (DE 9) al inicio frente a 11,5 (DE 7) a los 3 meses ( p < 0,001). El inicio de la MFG, asociado a un programa educativo estructurado, en pacientes adultos con DM1, se asoció a mejoría en la calidad de vida y a mayor satisfacción con el tratamiento de la diabetes. Se observó mejoría en la HbA1c y menor número de eventos de hipoglucemia, pero no hubo efectos en el resto de los parámetros glucémicos. Flash glucose monitoring (FGM) improves some glycaemic control variables and quality of life parameters. Our aim was to evaluate the quality of life and glycaemic control parameters after initiating FGM in patients with type 1 diabetes (DM1) in clinical practice. A prospective observational study in DM1 patients that started using FGM between June 2019 and April 2020. We analysed their scores on the Diabetes Quality of Life (DQOL) questionnaire, Diabetes Distress Scale (DDS), Diabetes Treatment Satisfaction Questionnaire (DTSQ) and glycaemic control parameters at baseline and 3 months after the FGM onset. We recruited 114 patients, 56% male, mean age 37.2 (standard deviation, SD 12.4), with 18.7 (SD 11.5) years of DM1, 24.6% of which used continuous subcutaneous insulin infusion. Differences were observed (baseline vs. 3 months) in the DTSQ score (22 [15.5-27] vs. 25 [22-28], P < 0.001) and in the DQOL score (88 [74-104] vs. 84 [70-101], P = 0.017) but not in the DDS score. HbA1c was 7.8% (SD 1.3) vs. 7.4% (SD 1.1) ( P < 0.001), without improvement in other glycaemic control variables, except for the mean number of hypoglycaemic events/14 days: 14 (SD 9) at baseline vs. 11.5 (SD 7) at 3 months ( P < 0.001). The initiation of FGM, combined with a structured educational programme, was associated with improvement in quality of life and patient satisfaction in DM1 patients. An improvement in HbA1c and a reduction in the number of hypoglycaemia events was observed, but not in the rest of glycaemic control parameters." @default.
• W3205422661 created "2021-10-25" @default.
• W3205422661 creator A5002188647 @default.
• W3205422661 creator A5004864100 @default.
• W3205422661 creator A5011515118 @default.
• W3205422661 creator A5025059356 @default.
• W3205422661 creator A5041632998 @default.
• W3205422661 creator A5043811119 @default.
• W3205422661 creator A5046150961 @default.
• W3205422661 creator A5053213234 @default.
• W3205422661 creator A5054551464 @default.
• W3205422661 creator A5067282594 @default.
• W3205422661 creator A5089422769 @default.
• W3205422661 date "2022-05-01" @default.
• W3205422661 modified "2023-10-02" @default.
• W3205422661 title "Impacto del inicio de la monitorización flash de glucosa en la calidad de vida y en los parámetros de control glucémico de pacientes adultos con diabetes tipo 1" @default.
• W3205422661 cites W1970862766 @default.
• W3205422661 cites W1988051819 @default.
• W3205422661 cites W2056930506 @default.
• W3205422661 cites W2077582378 @default.
• W3205422661 cites W2121360434 @default.
• W3205422661 cites W2418447640 @default.
• W3205422661 cites W2506743713 @default.
• W3205422661 cites W2519526531 @default.
• W3205422661 cites W2579602114 @default.
• W3205422661 cites W2771735617 @default.
• W3205422661 cites W2778308090 @default.
• W3205422661 cites W2779314348 @default.
• W3205422661 cites W2779903265 @default.
• W3205422661 cites W2808519967 @default.
• W3205422661 cites W2808881153 @default.
• W3205422661 cites W2900539459 @default.
• W3205422661 cites W2918861020 @default.
• W3205422661 cites W2950215271 @default.
• W3205422661 cites W2981551707 @default.
• W3205422661 cites W2996110789 @default.
• W3205422661 cites W2997941529 @default.
• W3205422661 cites W3005971343 @default.
• W3205422661 cites W3010981324 @default.
• W3205422661 cites W3028861995 @default.
• W3205422661 cites W4250602196 @default.
• W3205422661 doi "https://doi.org/10.1016/j.endinu.2021.05.011" @default.
• W3205422661 hasPublicationYear "2022" @default.
• W3205422661 type Work @default.
• W3205422661 sameAs 3205422661 @default.
• W3205422661 citedByCount "3" @default.
• W3205422661 countsByYear W32054226612023 @default.
• W3205422661 crossrefType "journal-article" @default.
• W3205422661 hasAuthorship W3205422661A5002188647 @default.
• W3205422661 hasAuthorship W3205422661A5004864100 @default.
• W3205422661 hasAuthorship W3205422661A5011515118 @default.
• W3205422661 hasAuthorship W3205422661A5025059356 @default.
• W3205422661 hasAuthorship W3205422661A5041632998 @default.
• W3205422661 hasAuthorship W3205422661A5043811119 @default.
• W3205422661 hasAuthorship W3205422661A5046150961 @default.
• W3205422661 hasAuthorship W3205422661A5053213234 @default.
• W3205422661 hasAuthorship W3205422661A5054551464 @default.
• W3205422661 hasAuthorship W3205422661A5067282594 @default.
• W3205422661 hasAuthorship W3205422661A5089422769 @default.
• W3205422661 hasConcept C142362112 @default.
• W3205422661 hasConcept C15708023 @default.
• W3205422661 hasConcept C29456083 @default.
• W3205422661 hasConcept C71924100 @default.
• W3205422661 hasConceptScore W3205422661C142362112 @default.
• W3205422661 hasConceptScore W3205422661C15708023 @default.
• W3205422661 hasConceptScore W3205422661C29456083 @default.
• W3205422661 hasConceptScore W3205422661C71924100 @default.
• W3205422661 hasIssue "5" @default.
• W3205422661 hasLocation W32054226611 @default.
• W3205422661 hasOpenAccess W3205422661 @default.
• W3205422661 hasPrimaryLocation W32054226611 @default.
• W3205422661 hasRelatedWork W1506200166 @default.
• W3205422661 hasRelatedWork W1995515455 @default.
• W3205422661 hasRelatedWork W2048182022 @default.
• W3205422661 hasRelatedWork W2080531066 @default.
• W3205422661 hasRelatedWork W2604872355 @default.
• W3205422661 hasRelatedWork W2748952813 @default.
• W3205422661 hasRelatedWork W2899084033 @default.
• W3205422661 hasRelatedWork W3031052312 @default.
• W3205422661 hasRelatedWork W3032375762 @default.
• W3205422661 hasRelatedWork W3108674512 @default.
• W3205422661 hasVolume "69" @default.
• W3205422661 isParatext "false" @default.
• W3205422661 isRetracted "false" @default.
• W3205422661 magId "3205422661" @default.
• W3205422661 workType "article" @default.